-
1دورية أكاديمية
المؤلفون: Naguy A; Naguy, MBBch, MSc, MRCPsych (UK), Psychiatrist, Kuwait Centre for Mental Health (KCMH), Jamal Abdul-Nassir St, Shuwaikh, State of Kuwait., Al-Khadhari S; Al-Khadhari, MBBch, FRCP(C), Professor of Psychiatry, Head of Psychiatric Department, Kuwait Faculty of Medicine, Kuwait.
المصدر: Psychopharmacology bulletin [Psychopharmacol Bull] 2024 Jul 08; Vol. 54 (3), pp. 100-102.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: MedWorks Media Country of Publication: United States NLM ID: 0101123 Publication Model: Print Cited Medium: Internet ISSN: 2472-2448 (Electronic) Linking ISSN: 00485764 NLM ISO Abbreviation: Psychopharmacol Bull Subsets: MEDLINE
مواضيع طبية MeSH: Paliperidone Palmitate*/adverse effects , Paliperidone Palmitate*/administration & dosage , Antipsychotic Agents*/adverse effects , Antipsychotic Agents*/administration & dosage, Humans ; Adolescent ; Psychotic Disorders/drug therapy ; Male ; Dyskinesia, Drug-Induced ; Female ; Dystonia/chemically induced
-
2دورية أكاديمية
المؤلفون: Nozawa H; Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan. Electronic address: hnozawa@hama-med.ac.jp., Minakata K; Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan., Hasegawa K; Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan., Yamagishi I; Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan., Miyoshi N; Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan., Yuyama K; Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan., Suzuki M; Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan., Kitamoto T; Advanced Research Facilities and Services, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan., Kondo M; Advanced Research Facilities and Services, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan., Suzuki O; Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan.
المصدر: Legal medicine (Tokyo, Japan) [Leg Med (Tokyo)] 2024 Jul; Vol. 69, pp. 102340. Date of Electronic Publication: 2023 Nov 05.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Elsevier Science Ireland Ltd Country of Publication: Ireland NLM ID: 100889186 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4162 (Electronic) Linking ISSN: 13446223 NLM ISO Abbreviation: Leg Med (Tokyo) Subsets: MEDLINE
-
3دورية أكاديمية
المؤلفون: Ishigooka J; Department of Psychiatry, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. ishigooka@i-cnsp.com.; Present address: Institute of CNS Pharmacology, 4-26-11 Sendagaya, Shibuya-ku, Tokyo, 151-0051, Japan. ishigooka@i-cnsp.com., Nakagome K; Department of Psychiatry, National Center of Neurology and Psychiatry, 4 Chome-1-1 Ogawahigashicho, Kodaira, Tokyo, 187-8551, Japan., Ohmori T; Department of Psychiatry, Tokushima University Graduate School of Biomedical Sciences, 3-18- 15, Kuramoto-cho, Tokushima, 770-8503, Japan., Iwata N; Department of Psychiatry, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan., Inada K; Department of Psychiatry, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.; Present address: Department of Psychiatry, Kitasato University School of Medicine, 1-15-1, Kitasato, Minami-ku, Sagamihara-shi, Kanagawa, 252-0374, Japan., Iga JI; Department of Psychiatry, Tokushima University Graduate School of Biomedical Sciences, 3-18- 15, Kuramoto-cho, Tokushima, 770-8503, Japan.; Present address: Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan., Kishi T; Department of Psychiatry, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan., Fujita K; Okehazama Hospital Fujita Kokoro Care Center, Minamiyakata, Sakaecho Toyoake, Aichi, 470-1168, Japan., Kikuchi Y; Department of Psychiatry, Akita University Hospital, Hasunuma-44-2 Hiroomote, Akita, 010- 0041, Japan.; Present address: Heart-Care Clinic Omachi, 1-2-7 Omachi, Akita, 010-0921, Japan., Shichijo T; Mental Clinic Minami, 4 Chome-3-2 Honcho, Iwatsuki Ward, Saitama, 339-0057, Japan., Tabuse H; Department of Psychiatry, Holy Cross Hospital, 2431-160 Kujiri, Izumi-cho, Toki-shi, Gifu, 509-5142, Japan., Koretsune S; Kokorono Clinic Narimasu, 3-3-15 Narimasu, Itabashi-ku, Tokyo, 175-0094, Japan., Terada H; Aoi Clinic, 679-1 Okitsunakacho, Shimizu Ward, Shizuoka, 424-0204, Japan., Terada H; Aoi Clinic, 679-1 Okitsunakacho, Shimizu Ward, Shizuoka, 424-0204, Japan., Kishimoto T; Department of Psychiatry, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8521, Japan.; Present address: Akitsu-Kounoike Hospital, 1064 Ikenouchi, Gose-shi, Nara, 639-2273, Japan., Tsutsumi Y; Department of Psychiatry, Ongata Hospital, 105 Nishiterakatamachi, Hachioji, Tokyo, 192- 0153, Japan., Ohi K; Department of Neuropsychiatry, Kokubu Hospital, 4-672 Asahigaoka, Kashiwara-shi, Osaka, 582-0026, Japan.; Present address: Department of Psychiatry and Psychotherapy, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1112, Japan.
المصدر: BMC psychiatry [BMC Psychiatry] 2024 Sep 05; Vol. 24 (1), pp. 600. Date of Electronic Publication: 2024 Sep 05.
نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
مواضيع طبية MeSH: Schizophrenia*/drug therapy , Antipsychotic Agents*/therapeutic use , Aripiprazole*/therapeutic use , Paliperidone Palmitate*/therapeutic use , Paliperidone Palmitate*/administration & dosage , Quality of Life*, Humans ; Male ; Female ; Adult ; Middle Aged ; Piperazines/therapeutic use ; Piperidines/therapeutic use ; Treatment Outcome ; Remission Induction ; Japan ; Psychiatric Status Rating Scales ; Schizophrenic Psychology
-
4دورية أكاديمية
المؤلفون: Benson C; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Titusville, NJ., Patel C; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Titusville, NJ., Lee I; IQVIA Inc., Durham, NC.; IQVIA Inc., Durham, NC at the time the study was conducted., Shaikh NF; IQVIA Inc., Durham, NC., Wang Y; IQVIA Inc., Durham, NC., Zhao X; IQVIA Inc., Durham, NC., Near AM; IQVIA Inc., Durham, NC.
المصدر: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Sep; Vol. 30 (9), pp. 954-966. Date of Electronic Publication: 2024 Jun 03.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE
مواضيع طبية MeSH: Paliperidone Palmitate*/administration & dosage , Paliperidone Palmitate*/economics , Paliperidone Palmitate*/therapeutic use , Schizophrenia*/drug therapy , Schizophrenia*/economics , Antipsychotic Agents*/economics , Antipsychotic Agents*/administration & dosage , Antipsychotic Agents*/therapeutic use , Hospitalization*/statistics & numerical data , Hospitalization*/economics , Psychotic Disorders*/drug therapy , Psychotic Disorders*/economics , Delayed-Action Preparations*, Humans ; Male ; Female ; Retrospective Studies ; Adult ; Middle Aged ; Young Adult ; Injections ; Cohort Studies
-
5Editorial & Opinion
المؤلفون: Sánchez-Alonso S; Department of Psychiatry, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Department of Personalidad, Evaluación y Psicología Clínica, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain., Baca-García E; Department of Psychiatry, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Department of Personalidad, Evaluación y Psicología Clínica, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.; Spanish Network for Research in Mental Health (CIBERSAM), Instituto de Salud, Carlos III, Madrid, Spain.; Department of Psychology, Universidad Católica del Maule, Talca, Chile.; Department of Psychiatry, Centre Hospitalier Universitaire de Nîmes, Nîmes, France., Ovejero S; Department of Psychiatry, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Department of Psychiatry, Autonomous University of Madrid, Madrid, Spain., de Leon J; Mental Health Research Center at Eastern State Hospital, Lexington, KY, USA.; Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain., Schoretsanitis G; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.; The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, NY, USA.; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
المصدر: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2024 Aug; Vol. 20 (8), pp. 709-712. Date of Electronic Publication: 2024 Jul 12.
نوع المنشور: Editorial
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7607 (Electronic) Linking ISSN: 17425255 NLM ISO Abbreviation: Expert Opin Drug Metab Toxicol Subsets: MEDLINE
-
6دورية أكاديمية
المؤلفون: T'jollyn H; Janssen Research & Development, LLC, Turnhoutseweg 30, 2340, Beerse, Belgium. htjollyn@its.jnj.com., Venkatasubramanian R; Janssen Research & Development, LLC, Titusville, NJ, USA., Neyens M; Janssen Research & Development, LLC, Turnhoutseweg 30, 2340, Beerse, Belgium., Gopal S; Janssen Research & Development, LLC, Titusville, NJ, USA.; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Russu A; Janssen Research & Development, LLC, Turnhoutseweg 30, 2340, Beerse, Belgium., Nandy P; Janssen Research & Development, LLC, Raritan, NJ, USA.; CSL Behring, King of Prussia, PA, USA., Perez-Ruixo JJ; Janssen Research & Development, LLC, Turnhoutseweg 30, 2340, Beerse, Belgium., Ackaert O; Janssen Research & Development, LLC, Turnhoutseweg 30, 2340, Beerse, Belgium.
المصدر: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Jul; Vol. 49 (4), pp. 491-506. Date of Electronic Publication: 2024 May 20.
نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
بيانات الدورية: Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE
مواضيع طبية MeSH: Paliperidone Palmitate*/pharmacokinetics , Paliperidone Palmitate*/administration & dosage , Schizophrenia*/drug therapy , Antipsychotic Agents*/pharmacokinetics , Antipsychotic Agents*/administration & dosage , Models, Biological*, Humans ; Adult ; Male ; Female ; Injections, Intramuscular ; Middle Aged ; Double-Blind Method ; Computer Simulation ; Drug Administration Schedule ; Dose-Response Relationship, Drug ; Young Adult ; Delayed-Action Preparations/pharmacokinetics ; Adolescent
-
7دورية أكاديمية
المؤلفون: Correll CU; Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York.; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.; Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Center for Mental Health, Berlin, Germany., Johnston K; Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Titusville, New Jersey., Turkoz I; Janssen Research & Development, LLC, Titusville, New Jersey., Gray J; Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Titusville, New Jersey., Sun L; Cytel, Cambridge, Massachusetts., Doring M; Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Titusville, New Jersey., Sajatovic M; University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
المصدر: JAMA network open [JAMA Netw Open] 2024 Jul 01; Vol. 7 (7), pp. e2421495. Date of Electronic Publication: 2024 Jul 01.
نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study
بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
مواضيع طبية MeSH: Schizophrenia*/drug therapy , Paliperidone Palmitate*/therapeutic use , Paliperidone Palmitate*/administration & dosage , Paliperidone Palmitate*/adverse effects , Antipsychotic Agents*/therapeutic use , Antipsychotic Agents*/administration & dosage, Humans ; Male ; Female ; Adult ; Middle Aged ; Double-Blind Method ; Treatment Outcome ; Delayed-Action Preparations/therapeutic use
-
8تقرير
المؤلفون: Clark I; Pharmacy Department, Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK., Wallman P; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Gee S; Pharmacy Department, Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK., Taylor D; Pharmacy Department, Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
المصدر: Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2024 Jul; Vol. 150 (1), pp. 48-50. Date of Electronic Publication: 2024 Apr 15.
نوع المنشور: Letter; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370364 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0447 (Electronic) Linking ISSN: 0001690X NLM ISO Abbreviation: Acta Psychiatr Scand Subsets: MEDLINE
-
9دورية أكاديمية
المؤلفون: T'jollyn H; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Belgium. htjollyn@its.jnj.com., Russu A; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Belgium., Venkatasubramanian R; Janssen Research and Development, LLC, Titusville, NJ, USA., Gopal S; Janssen Research and Development, LLC, Titusville, NJ, USA.; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Nandy P; Janssen Research and Development, LLC, Titusville, NJ, USA.; CSL Behring, King of Prussia, PA, USA., Neyens M; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Belgium., Faelens R; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Belgium., Samtani MN; Janssen Research and Development, LLC, Titusville, NJ, USA., Ackaert O; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Belgium., Perez-Ruixo JJ; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Belgium.
المصدر: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Jul; Vol. 49 (4), pp. 477-489. Date of Electronic Publication: 2024 May 15.
نوع المنشور: Journal Article; Clinical Trial, Phase III
بيانات الدورية: Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE
مواضيع طبية MeSH: Paliperidone Palmitate*/pharmacokinetics , Paliperidone Palmitate*/administration & dosage , Paliperidone Palmitate*/adverse effects , Schizophrenia*/drug therapy , Antipsychotic Agents*/pharmacokinetics , Antipsychotic Agents*/administration & dosage, Humans ; Models, Biological ; Drug Administration Schedule ; Adult ; Male ; Female ; Drug Development/methods ; Computer Simulation
-
10دورية أكاديمية
المؤلفون: Konishi T; Department of Pharmacy, Kobe University Hospital, Kobe, Japan., Kitahiro Y; Department of Pharmacy, Kobe University Hospital, Kobe, Japan., Fujiwara N; Department of Pharmacy, Kobe University Hospital, Kobe, Japan., Yamamoto K; Department of Pharmacy, Kobe University Hospital, Kobe, Japan., Hashimoto M; Department of Pharmacy, Kobe University Hospital, Kobe, Japan., Ito T; Department of Pharmacy, Kobe University Hospital, Kobe, Japan., Itohara K; Department of Pharmacy, Kobe University Hospital, Kobe, Japan., Fujioka K; Division of Pediatrics, Graduate School of Medicine, Kobe University, Kobe, Japan., Imafuku H; Division of Obstetrics and Gynecology, Graduate School of Medicine, Kobe University, Kobe, Japan ; and., Otsuka I; Department of Psychiatry, Graduate School of Medicine, Kobe University, Kobe, Japan ., Omura T; Department of Pharmacy, Kobe University Hospital, Kobe, Japan., Yano I; Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
المصدر: Therapeutic drug monitoring [Ther Drug Monit] 2024 Oct 01; Vol. 46 (5), pp. 687-691. Date of Electronic Publication: 2024 Apr 04.
نوع المنشور: Journal Article; Case Reports
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE
مواضيع طبية MeSH: Paliperidone Palmitate*/pharmacokinetics , Paliperidone Palmitate*/therapeutic use , Quetiapine Fumarate*/pharmacokinetics , Quetiapine Fumarate*/therapeutic use , Antipsychotic Agents*/pharmacokinetics , Antipsychotic Agents*/blood , Antipsychotic Agents*/therapeutic use , Risperidone*/pharmacokinetics , Risperidone*/blood , Risperidone*/therapeutic use , Milk, Human*/metabolism , Milk, Human*/chemistry , Schizophrenia*/drug therapy , Schizophrenia*/metabolism , Postpartum Period* , Thiophenes*/pharmacokinetics , Thiophenes*/blood , Quinolones*/pharmacokinetics , Quinolones*/blood , Quinolones*/therapeutic use, Humans ; Female ; Adult ; Pregnancy ; Infant, Newborn ; Tandem Mass Spectrometry/methods ; Fetal Blood/chemistry ; Fetal Blood/metabolism ; Pregnancy Complications/drug therapy